Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

You must log in to access content on this page. Or click here to request access.
Our focus is on making a measurable difference in global health.

MediBeacon is a medical technology company focused on developing fluorescent tracer agents and transdermal detection technology to help provide vital and actionable measurement of organ function.


In 2015, Pansend Life Sciences of INNOVATE Corp. (NYSE: VATE) became the largest equity investor in MediBeacon.


In 2019, MediBeacon entered into a $30 million investment and exclusive commercialization partnership in Greater China with Huadong Medicine Co., Ltd. Huadong is a leading Chinese-based pharmaceutical company listed on the Shenzhen Stock Exchange.